FDA Grants Orphan Drug Designation to Investigational CAR T-Cell Agent in Gastric/GEJ Cancer
The FDA granted Orphan Drug designation to CARsgen Therapeutics for a CAR T-cell treatment it’s developing to treat gastric cancer.
Immune Protein IL-17A Responsible for Lethal Side Effects of Gastric Cancer
Researchers in Japan discovered that the pro-inflammatory cytokine IL-17A plays a role in promoting peritoneal spread in gastric cancer, and they suggested... Read More
Drug-Drug Interactions to Avoid in Patients With GI Cancer
People with HER2-positive gastric cancer should not take proton pump inhibitors for heartburn while they are undergoing treatment, recent studies have found.
The role of tumor-associated macrophages in gastric cancer development and their potential as a therapeutic target
Tumor-associated macrophages represent an exciting new target in the development of treatments for gastric cancer.
ALX Oncology’s ALX148 Receives Two Fast Track Designations from FDA for the Treatment of Patients with Head and Neck Squamous Cell Carcinoma and Patients with Gastric or Gastroesophageal Junction Adenocarcinoma
ALX Oncology won fast-track designation from the FDA for its drug ALX148 in the second-line treatment of patients with HER2-positive gastric cancer.
Manish Shah, MD, discusses avelumab’s effectiveness based on results from the JAVELIN 100 study
Manish Shah of Weill Cornell Medicine explains the results of a recent study in which gastric cancer patients given either chemo or... Read More
More muscle, more protein may improve odds of surviving cancer: study
A review of nearly 150 studies reveals that a diet focused on maintaining muscle mass improves treatment response and survival in cancer... Read More
Association of Acupuncture and Acupressure With Improved Cancer Pain
A review of clinical trials reveals that acupuncture and acupressure help reduce pain and opioid usage in cancer patients.
Gritstone posts ‘one of the most potent immunogenic-responses for a neoantigen vaccine’
Two patients with gastroesophageal cancer responded well to Gritstone Oncology’s immune-stimulating treatment in an early trial.
Imugene welcomes receipt of US Department of Defense grant for City of Hope cancer researchers
City of Hope has received a $564,000 grant from the Department of Defense to study a cancer-fighting virus in the treatment of... Read More
